Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04449653
Other study ID # MEASURE
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 28, 2020
Est. completion date June 1, 2021

Study information

Verified date June 2020
Source Progentec Diagnostics, Inc.
Contact Eldon Jupe, Ph.D.
Phone 4052164818
Email ejupe@progentec.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

OASIS: A mobile study to measure and predict lupus (SLE) disease activity using digital signals The OASIS study is exploring how patient reported data and digital biomarkers, like activity level and heart rate variability, can be used to predict changes in lupus disease activity. You may receive a Withings Steel HR smartwatch as part of this study. The purpose of this study is to look for factors that affect lupus disease activity and potentially predict lupus flares through non-clinical tests


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date June 1, 2021
Est. primary completion date December 31, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Female or male age 18 or older

- Participant is currently not enrolled in another study

- Able to understand the requirements of the study, provide written informed consent, including consent for the use and disclosure of research-related health information, and comply with the study data collection procedures

Exclusion Criteria:

- NOT able to understand the requirements of the study, provide written informed consent, including consent for the use and disclosure of research-related health information, and comply with the study data collection procedures

- Known to be pregnant

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Ryan Newhardt Oklahoma City Oklahoma

Sponsors (1)

Lead Sponsor Collaborator
Progentec Diagnostics, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other OASIS Baseline Questionnaire Basic Health Information and SLE-specific questions Baseline, entered only upon enrollment
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week two
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week three
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week four
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week five
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week six
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week seven
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week eight
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week nine
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week ten
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week eleven
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week twelve
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week thirteen
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week fourteen
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week fifteen
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week sixteen
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week seventeen
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week eighteen
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week nineteen
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week twenty
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week twenty-one
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week twenty-two
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week twenty-three
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week twenty-four
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week twenty-five
Primary OASIS Wellness and Disease Questionnaire Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week Week twenty-six
Primary Short Form, 36 question form 36 questions asking individuals questions about their general health and wellness, not disease-specific Month one
Primary Short Form, 36 question form 36 questions asking individuals questions about their general health and wellness, not disease-specific Month two
Primary Short Form, 36 question form 36 questions asking individuals questions about their general health and wellness, not disease-specific Month three
Primary Short Form, 36 question form 36 questions asking individuals questions about their general health and wellness, not disease-specific Month four
Primary Short Form, 36 question form 36 questions asking individuals questions about their general health and wellness, not disease-specific Month five
Primary Short Form, 36 question form 36 questions asking individuals questions about their general health and wellness, not disease-specific Month six
Primary Withings Heartrate & Activity Patient activity, sleep quality, and heart rate collected by the wearable watch Continuously, for six months
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week two
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week three
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week four
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week five
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week six
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week seven
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week eight
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week nine
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week ten
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week eleven
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week twelve
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week thirteen
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week fourteen
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week fifteen
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week sixteen
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week seventeen
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week eighteen
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week nineteen
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week twenty
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week twenty-one
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week twenty-two
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week twenty-three
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week twenty-four
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week twenty-five
Secondary Heart rate variability Measurement of individual's change in pulse via a smartphone's onboard camera Week twenty-six
See also
  Status Clinical Trial Phase
Completed NCT03248518 - Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases N/A
Recruiting NCT05967520 - JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus Phase 2
Completed NCT02875691 - Effect of Green Tea on Treatment of Lupus Phase 2
Completed NCT02922114 - Comparison of the Clinical Examination and the Joint Ultrasonography in Lupus Patients N/A
Withdrawn NCT01702038 - Determining the Responses and Impact of Rituximab-instigated Cell Depletion on T Cells in People With SLE Phase 2
Terminated NCT00368264 - TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL ) Phase 2/Phase 3
Completed NCT00094380 - Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077) Phase 1/Phase 2
Completed NCT00065806 - Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Phase 3
Completed NCT00005436 - Lupus Cohort--Thrombotic Events and Coronary Artery Disease N/A
Recruiting NCT03543839 - Trial of Belimumab in Early Lupus Phase 4
Completed NCT03098823 - A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE Phase 4
Recruiting NCT05899907 - Efficacy and Safety of Telitacicept in Early SLE Phase 4
Completed NCT04956484 - Belimumab In Early Systemic Lupus Erythematosus Phase 4
Completed NCT05326841 - Effect of Cholecalciferol Supplementation on Disease Activity and Quality of Life of Systemic Lupus Erythematosus Patients . Phase 3
Completed NCT02655640 - The Impact of Illness Perceptions on Health Related Outcomes in Patients With Lupus and Systemic Sclerosis N/A
Completed NCT02034344 - A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers Phase 0
Terminated NCT00089804 - Study of LJP 394 in Lupus Patients With History of Renal Disease Phase 3
Completed NCT00071487 - Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE) Phase 2
Completed NCT02349061 - A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus Phase 2
Recruiting NCT05636670 - Assessment of Cognitive Function and Gut Microbiota Analysis in Real World Patients With Lupus Cerebrovascular Disease